ivacaftor 75 MG Oral Tablet

RxCUI: 2174388
RxNorm name: ivacaftor 75 MG Oral Tablet
Display name: ivacaftor 75 MG Oral Tablet
Full name: ivacaftor 75 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Trikafta	ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR	Vertex Pharmaceuticals Incorporated	f354423a-85c2-41c3-a9db-0f3aee135d8d	2026-06-22	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2174388

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f354423a-85c2-41c3-a9db-0f3aee135d8d	ivacaftor 75 MG Oral Tablet [PSN] · ivacaftor 75 MG Oral Tablet [SCD]	2	22	These highlights do not include all the information needed to use TRIKAFTA safely and effectively. See full prescribing information for TRIKAFTA. TRIKAFTA ® (elexacaftor, tezacaftor, and ivacaftor tablets; ivacaftor tablets), co-packaged for oral use TRIKAFTA ® (elexacaftor, tezacaftor, and ivacaftor oral granules; ivacaftor oral granules), co-packaged Initial U.S. Approval: 2019	20260323
302ae804-37db-44fd-ac2f-3dbdeda9aa4b	ivacaftor 75 MG Oral Tablet [PSN] · ivacaftor 75 MG Oral Tablet [SCD]	2	21	These highlights do not include all the information needed to use SYMDEKO safely and effectively. See full prescribing information for SYMDEKO. SYMDEKO ® (tezacaftor/ivacaftor) tablets; (ivacaftor) tablets, for oral use Initial U.S. Approval: 2018	20260324